FDA Approved: DURACLON — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for DURACLON (clonidine hydrochloride) from Mylan Institutional LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Hypertension

Drugs mentioned

• DURACLON (Clonidine hydrochloride)

Snippet

SUPPL AP for DURACLON (CLONIDINE HYDROCHLORIDE)